Edition:
India

STADA Arzneimittel AG (STAGn.DE)

STAGn.DE on Xetra

81.00EUR
17 Nov 2017
Change (% chg)

€0.20 (+0.25%)
Prev Close
€80.80
Open
€80.60
Day's High
€81.10
Day's Low
€80.38
Volume
32,484
Avg. Vol
203,098
52-wk High
€83.91
52-wk Low
€42.53

Select another date:

Thu, Nov 9 2017

BRIEF-Stada confident domination agreement can be struck in Q1 2018

* CEO says are confident that a profit and domination agreement with Elliott can be concluded at an EGM in Q1 2018 Further company coverage:

BRIEF-Appointment of five new supervisory board members at Stada -Bain Capital, Cinven

* dgap-news: bain capital and cinven announce appointment of five new supervisory board members at stada Source text for Eikon: Further company coverage: (Frankfurt newsroom)

BRIEF-Stada says elects Guenter von Au as new chairman

* dgap-adhoc: stada arzneimittel ag: supervisory board of stada arzneimittel ag elects dr. Günter von au as new chairman Source text for Eikon: Further company coverage: (Frankfurt newsroom)

BRIEF-Stada says investigation finds no misconduct by execs

* Says external law firm’s investigation of certain former execs didn't find evidence of self-enrichment, bribery or other criminal activity‍​

BRIEF-Bain, Cinven say expect Stada takeover to close next week

* Final result of successful takeover offer for Stada by Bain Capital and Cinven

LPC-Stada’s giant €2.35bn buyout loan launches

LONDON, Sept 4 A €2.35bn jumbo loan financing backing private equity groups Bain Capital and Cinven’s buyout of German generic drugmaker Stada has launched to Europe’s leveraged loan market, banking sources said on Monday.

RPT-UPDATE 1-Bain, Cinven give in to Elliott's demand for higher Stada buyout

FRANKFURT, Sept 4 Bain Capital and Cinven will offer minority Stada shareholders a marked-up 74.40 euros per share to get full control of the German generic drugmaker, the buyout groups said, giving in to pressure from hold-out investor Elliott Management.

Bain, Cinven give in to Elliott's demand for higher Stada buyout

FRANKFURT Bain Capital and Cinven will offer minority Stada shareholders a marked-up 74.40 euros per share to get full control of the German generic drugmaker, the buyout groups said, giving in to pressure from hold-out investor Elliott Management.

UPDATE 1-Bain, Cinven give in to Elliott's demand for higher Stada buyout

* Shares jump 3.2 percent to 82.05 euros (Adds new total value, mark-up, updates shares)

Bain, Cinven give in to Elliott's demand for higher Stada buyout

FRANKFURT, Sept 4 Buyout groups Bain Capital and Cinven said they would propose to Stada's management to offer minority shareholders cash compensation of 74.40 euros per share, giving in to pressure from activist investor Elliott.

Select another date: